Aspire Biopharma Holdings (ASBP) Stock on Dec. 15, 2025: Nasdaq Extension, FDA Pre‑IND Momentum, and Dilution Risks Investors Are Watching

Aspire Biopharma Holdings (ASBP) Stock on Dec. 15, 2025: Nasdaq Extension, FDA Pre‑IND Momentum, and Dilution Risks Investors Are Watching

Aspire Biopharma shares fell about 8% to $0.095 on December 15, 2025, as the company’s stock transferred from the Nasdaq Global Select Market to the Nasdaq Capital Market. Aspire faces Nasdaq deadlines to regain compliance with minimum bid price and equity rules by early 2026. The company is also advancing an FDA regulatory milestone for its sublingual aspirin program.
15 December 2025
Opendoor Technologies (OPEN) Stock Today: Latest News, Warrant Dividend Impact, Analyst Forecasts, and What Investors Are Watching (Dec. 15, 2025)

Opendoor Technologies (OPEN) Stock Today: Latest News, Warrant Dividend Impact, Analyst Forecasts, and What Investors Are Watching (Dec. 15, 2025)

Opendoor shares fell nearly 7% to $6.56 at Monday’s open, continuing a year of sharp swings. The company is undergoing a major shift under new CEO Kaz Nejatian, with a focus on AI and software. A special dividend of tradable warrants and skepticism from analysts have added to volatility. Market cap stands at about $6.3 billion.
15 December 2025
GameStop Stock (GME) Today: Q3 2025 Earnings, Bitcoin Treasury Update, and Analyst Forecasts as of Dec. 15, 2025

GameStop Stock (GME) Today: Q3 2025 Earnings, Bitcoin Treasury Update, and Analyst Forecasts as of Dec. 15, 2025

GameStop Corp. (NYSE: GME) is back in the spotlight as investors weigh a familiar mix of ingredients: a shrinking legacy retail business, an expanding collectibles push, an enormous cash position, and a newly explicit Bitcoin treasury strategy—plus the ever-present “meme stock” volatility that refuses to die. As of Monday, December 15, 2025, GameStop shares were trading around $21 (roughly $21.23 mid-session), after moving between about $21.16 and $22.23 intraday. What’s driving attention right now is GameStop’s fiscal Q3 2025 report (quarter ended November 1, 2025) and the related Form 10‑Q, filed on December 9, 2025—where the company laid out, in
Equinox Gold Corp Stock (EQX) in Focus After $1.015 Billion Brazil Mine Sale to CMOC: Latest News, Forecasts, and Key Levels to Watch (Dec. 15, 2025)

Equinox Gold Corp Stock (EQX) in Focus After $1.015 Billion Brazil Mine Sale to CMOC: Latest News, Forecasts, and Key Levels to Watch (Dec. 15, 2025)

Equinox Gold Corp agreed to sell its Brazil operations to a CMOC Group subsidiary for $1.015 billion, including $900 million upfront and up to $115 million contingent on production. Shares traded near $14.70 on Monday after the news. The deal is expected to close in Q1 2026, pending regulatory approvals in Brazil and China. Equinox plans to focus on North American assets.
Beyond Meat Stock (BYND) News, Forecasts, and Analyst Outlook — What Matters on December 15, 2025

Beyond Meat Stock (BYND) News, Forecasts, and Analyst Outlook — What Matters on December 15, 2025

Beyond Meat, Inc. (NASDAQ: BYND) is back in its “extreme volatility” era — except this time the fuel isn’t hype about the future of food. It’s a heady mix of heavy dilution, a reworked debt stack, meme-stock style trading dynamics, and a business still wrestling with weak demand. As of December 15, 2025, BYND was trading around $1.09. That dollar-and-change price tag is the headline — but it’s not the whole story. What really matters for investors following Beyond Meat stock right now is how the company’s balance-sheet rescue reshaped the share count, how soon the market could see additional
15 December 2025
ServiceNow Stock (NYSE: NOW) News Today: Armis Deal Talk, 5-for-1 Split Countdown, and Wall Street Forecasts (Dec. 15, 2025)

ServiceNow Stock (NYSE: NOW) News Today: Armis Deal Talk, 5-for-1 Split Countdown, and Wall Street Forecasts (Dec. 15, 2025)

ServiceNow is in advanced talks to acquire cybersecurity firm Armis for up to $7 billion, according to Reuters. Shares traded near $865 early Dec. 15, down modestly and about 28% below the 52-week high. A 5-for-1 stock split is set for later this week. ServiceNow recently announced plans to buy identity security company Veza, pending regulatory approval.
15 December 2025
Applied Digital Corporation (APLD) Stock News, Forecasts and Analysis — What Investors Are Watching on Dec. 15, 2025

Applied Digital Corporation (APLD) Stock News, Forecasts and Analysis — What Investors Are Watching on Dec. 15, 2025

Applied Digital shares closed at $27.86 on December 15, down 9.4% in one session after a strong multi-month rally. The company, now valued near $7–8 billion, has shifted focus from crypto to AI data centers, highlighted by two 15-year CoreWeave leases worth $7 billion. Investors cite volatility and risks tied to capital needs and tenant concentration.
15 December 2025
Oscar Health Stock (OSCR) News Today: ACA Subsidy Cliff, Analyst Price Targets, and 2026 Open Enrollment Signals (Dec. 15, 2025)

Oscar Health Stock (OSCR) News Today: ACA Subsidy Cliff, Analyst Price Targets, and 2026 Open Enrollment Signals (Dec. 15, 2025)

Oscar Health shares traded near $16.63 on December 15, 2025, as the ACA open enrollment deadline coincided with new analyst coverage and policy debate in Washington. Congress is weighing the fate of enhanced ACA premium tax credits set to expire at the end of 2025. KFF projects average subsidized premiums could more than double in 2026 if subsidies lapse. Oscar’s business is heavily exposed to these ACA marketplace shifts.
15 December 2025
Sanofi Stock (SAN.PA, SNY) Slides After Tolebrutinib Double Setback: FDA Delay, Trial Miss, and Fresh Analyst Forecasts (Dec. 15, 2025)

Sanofi Stock (SAN.PA, SNY) Slides After Tolebrutinib Double Setback: FDA Delay, Trial Miss, and Fresh Analyst Forecasts (Dec. 15, 2025)

Sanofi shares fell about 4% in Paris on December 15 after the company reported a U.S. regulatory delay for tolebrutinib in non-relapsing secondary progressive MS and a failed Phase 3 trial in primary progressive MS. Sanofi will not seek approval for the latter indication. The FDA decision for nrSPMS is now expected after December 28, with further guidance by end of Q1 2026.
Alibaba Stock (BABA) Today: Price, Latest News, Analyst Forecasts and 2026 Outlook as AI Spending Accelerates

Alibaba Stock (BABA) Today: Price, Latest News, Analyst Forecasts and 2026 Outlook as AI Spending Accelerates

Alibaba’s U.S.-listed shares traded near $155.68 on Dec. 15, 2025, within a volatile 52-week range of $80.06 to $192.67. The company has committed over $52 billion to AI and cloud infrastructure, raising concerns about rising capital expenditures outpacing revenue. Its Qwen AI app surpassed 10 million downloads in its first week and is now integrated into Quark, reaching over 200 million users in China.
New Fortress Energy (NFE) Stock Today (Dec. 15, 2025): Debt Deadline, Puerto Rico Contract, and Analyst Forecasts Collide

New Fortress Energy (NFE) Stock Today (Dec. 15, 2025): Debt Deadline, Puerto Rico Contract, and Analyst Forecasts Collide

New Fortress Energy shares traded near $1.26 Monday, down 2.3%, as the company faces a December 15 deadline tied to a forbearance agreement on missed interest payments for its 2029 Notes. The agreement covers holders of over 70% of the notes and could trigger acceleration of debt if not extended or restructured. The stock sits near its 52-week low after a year of heavy volatility. Investors remain focused on debt negotiations.
15 December 2025
WORK Medical Technology Group LTD (NASDAQ: WOK) Stock: Today’s News, Nasdaq Compliance Risks, Dilution Watch, and Forecasts (Dec. 15, 2025)

WORK Medical Technology Group LTD (NASDAQ: WOK) Stock: Today’s News, Nasdaq Compliance Risks, Dilution Watch, and Forecasts (Dec. 15, 2025)

WORK Medical Technology Group (Nasdaq: WOK) traded around $0.11 on Dec. 15, 2025, after a 1-for-100 reverse split and repeated Nasdaq bid-price warnings. The stock’s 52-week range shows extreme volatility, distorted by the split and thin trading. A Nasdaq volatility halt was triggered on Dec. 10. The company supplies medical devices in China and exports to over 30 countries.
15 December 2025
Celestica Inc Stock (CLS) News Today: Why Shares Slid, What Analysts Forecast, and What to Watch Next

Celestica Inc Stock (CLS) News Today: Why Shares Slid, What Analysts Forecast, and What to Watch Next

Celestica shares fell 12.78% to $306.50 on December 12 amid a broader tech selloff linked to concerns over AI valuations and rising borrowing costs. The stock rebounded in early pre-market trading December 15, indicated at $312.10. B. Riley Wealth Advisors disclosed a new stake of 11,319 shares, while director Laurette T. Koellner bought 6,000 shares in October. Institutional investors hold about 67% of Celestica shares.
15 December 2025
ZIM Stock (NYSE: ZIM) in Focus: Takeover Bids, Proxy Fight, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

ZIM Stock (NYSE: ZIM) in Focus: Takeover Bids, Proxy Fight, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

ZIM Integrated Shipping shares fell 5.4% to $18.76 on Dec. 15, 2025, amid takeover speculation and a pending shareholder vote. The board confirmed a strategic review after receiving a non-binding acquisition proposal from CEO Eli Glickman and Rami Ungar. Reports say MSC and Hapag-Lloyd have also submitted bids. Any sale would require shareholder and Israeli government approval.
Geminids Meteor Shower 2025: The Asteroid Behind Today’s Shooting Stars (Dec. 15 Updates)

Geminids Meteor Shower 2025: The Asteroid Behind Today’s Shooting Stars (Dec. 15 Updates)

On December 15, 2025, the Geminids — often called the year’s most reliable “shooting star” show — are still making headlines around the world. While peak activity has largely passed, late-season Geminid meteors are continuing to streak across dark skies, and today’s coverage has put renewed focus on the shower’s strangest detail: the Geminids come from an asteroid, not a comet. NASA Science+1 If you’re searching for “Geminids asteroid today,” you’re almost certainly looking for the story of asteroid 3200 Phaethon — a rocky object that behaves like a comet at times, leaving behind the debris Earth plows into each December. NASA Science+1 Geminids meteor shower
15 December 2025
Canada Economic Calendar Today (Dec. 15, 2025): CPI, Housing Starts and Factory Data in Focus as Bank of Canada Watchers Brace for Volatility

Canada Economic Calendar Today (Dec. 15, 2025): CPI, Housing Starts and Factory Data in Focus as Bank of Canada Watchers Brace for Volatility

Canada’s November Consumer Price Index was released this morning, with economists split on whether inflation edged up to 2.3% or held at 2.2%. Earlier, national home sales slipped 0.6% in November and the average home price fell 2% year-over-year to $682,219, according to CREA. Housing starts and manufacturing data are also due this morning.
15 December 2025
US Economic Calendar Today (Dec. 15, 2025): Empire State Manufacturing, NAHB Housing Index, Fed Speaker Williams, and Treasury Bill Auctions

US Economic Calendar Today (Dec. 15, 2025): Empire State Manufacturing, NAHB Housing Index, Fed Speaker Williams, and Treasury Bill Auctions

The Empire State Manufacturing Survey is due at 8:30 a.m. ET, with forecasts expecting a drop to 10.0 from 18.7. The NAHB/Wells Fargo Housing Market Index follows at 10:00 a.m., with builder confidence seen edging up to 39. Markets remain alert after a record U.S. government shutdown delayed key data and disrupted economic reporting.
15 December 2025
Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

The FDA approved Milestone Pharmaceuticals’ CARDAMYST (etripamil) nasal spray for adults with paroxysmal supraventricular tachycardia, marking the first new U.S. PSVT treatment in over 30 years. The company targets retail availability in Q1 2026. Shares showed sharp volatility after the announcement. Milestone scheduled an investor call for December 15 to discuss launch plans.
GE Aerospace Stock (NYSE: GE) News Today: Citi’s $386 Target, FAA LEAP Inspections, Navy Orders, and What to Watch Into 2026

GE Aerospace Stock (NYSE: GE) News Today: Citi’s $386 Target, FAA LEAP Inspections, Navy Orders, and What to Watch Into 2026

GE Aerospace shares rose about 4% to $299.81, following Citigroup’s initiation of coverage with a Buy rating and $386 target. The company also secured orders to supply LM2500 engines for two U.S. Navy destroyers. Meanwhile, the FAA issued a new airworthiness directive for certain CFM LEAP-1A engines after reports of blade cracks.

Stock Market Today

KKR stock rebounds 4% after earnings shock; what investors watch before Monday’s open

KKR stock rebounds 4% after earnings shock; what investors watch before Monday’s open

8 February 2026
KKR shares jumped 4.06% to $103.20 Friday, rebounding from a steep drop the day before as trading volume surged. The firm disclosed a $1.4 billion deal to acquire Arctos and set an April 21 vote on governance changes, including a shift to one-vote-per-share by the end of 2026. Investors remain focused on KKR’s software exposure and loan leverage after an AI-driven selloff hit the sector.
Take-Two stock snaps back Friday — the next dates TTWO traders are watching

Take-Two stock snaps back Friday — the next dates TTWO traders are watching

8 February 2026
Take-Two Interactive shares closed up 1.22% at $195.59 Friday, trading between $189.45 and $198.07 on 3.1 million shares. The company reaffirmed Grand Theft Auto VI’s Nov. 19, 2026 release and raised its fiscal 2026 net bookings outlook to as much as $6.7 billion. The Dow closed above 50,000 for the first time.
Gold.com (GOLD) stock jumps nearly 10% as Tether deal and earnings reshape the week ahead

Gold.com (GOLD) stock jumps nearly 10% as Tether deal and earnings reshape the week ahead

8 February 2026
Gold.com, Inc. shares jumped 9.9% to $55.32 Friday after the company announced a $150 million share sale to Tether at an 11.9% discount, with $125 million closing first and the rest pending regulatory approval. Trading volume more than doubled the average. Gold.com posted Q2 revenue of $6.48 billion and net income of $11.6 million, and completed its Monex acquisition in January.
Go toTop